Vistide recall: Particulate Matter
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3…
Why was Vistide recalled?
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: B120217A, Exp 05/15 - US Distribution
- Product
- Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3…
- Recalling firm
- Gilead Sciences, Inc.
- Quantity
- 3,181 vials
- Distribution
- Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.
- Recall date
- May 22, 2013
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)